Milestone Scientific Inc. (MLSS) |
| 0.505 -0.034 (-6.38%) 08-27 16:00 |
| Open: | 0.54 |
| High: | 0.54 |
| Low: | 0.4891 |
| Volume: | 140,749 |
| Market Cap: | 45(M) |
| PE Ratio: | -10.1 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.68 |
| Resistance 1: | 0.58 |
| Pivot price: | 0.50 |
| Support 1: | 0.45 |
| Support 2: | 0.37 |
| 52w High: | 0.65 |
| 52w Low: | 0.22 |
Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical. Within its Dental division, key products include CompuDent and the STA Single Tooth Anesthesia System, both instrumental for delivering local anesthetics across all dental procedures. For broader applications, the firm offers CompuFlo, a sophisticated computer-controlled system capable of delivering drugs, anesthetics, and other medicaments comfortably and precisely, as well as aspirating bodily fluids or prior injections. Complementing this, a disposable injection handpiece provides precise tactile control during administration. In the Medical segment, Milestone Scientific introduces the CompuFlo Epidural, a computer-guided anesthesia system designed for a variety of medical applications. Additionally, their CompuMed system is utilized in numerous specialized procedures, including plastic surgery, hair restoration, colorectal surgery, podiatry, dermatology, and orthopedics, among others. Headquartered in Livingston, New Jersey, Milestone Scientific Inc. was established in 1989.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Wed, 26 Aug 2026
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors - The Manila Times
Wed, 26 Aug 2026
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors - Moomoo
Fri, 14 Aug 2026
Transcript: Milestone Scientific Q2 2026 Earnings Conference Call - Benzinga
Fri, 14 Aug 2026
Milestone Scientific Reports 231% Growth in Medical Revenue, Announces VA and DoD Distribution Agreement and Reaffirms 2026 Outlook - Quiver Quantitative
Thu, 13 Aug 2026
Milestone Scientific (NYSE: MLSS) grows revenue 22% but flags going concern risk - Stock Titan
Thu, 13 Aug 2026
Earnings To Watch: Milestone Scientific Inc (MLSS) Q2 2026 -- GF Value Sees 13% Upside - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |